MYH9-related disorders

Report on a patient of greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation

Marina Economou, Spyros P. Batzios, Alessandro Pecci, Nikoletta Printza, Anna Savoia, Serena Barozzi, Stamatia Theodoridou, Aikaterini Teli, Georgios Psillas, Dimitrios I. Zafeiriou

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Myosin heavy chain-9 (MYH9)-related disorders represent a heterogenous group of hereditary diseases caused by mutations in the gene encoding the heavy chain of nonmuscle myosin IIA. May-Hegglin anomaly and Fechtner, Sebastian, and Epstein syndromes are the four phenotypes of the disease, characterized by congenital macrothrombocytopenia and distinguished by different combinations of clinical signs that may include glomerulonephritis, sensorineural hearing loss, and presenile cataract. The spectrum of mutations responsible for the disease is wide and the existence of genotype-phenotype correlation remains a critical issue. We report the first case of an MYH9-RD in a patient of Greek origin presenting with macroscopic hematuria and presenile cataract caused by a p.R1165C mutation. The same mutation was present in the patient's father, who exhibited no extrahematological features of the disease. The p.R1165C mutation is one of the MYH9 alterations whose prognostic significance is still poorly defined. Thus, the patients described add to the limited existing data on the MYH9 mutations and their resultant phenotypes.

Original languageEnglish
Pages (from-to)412-415
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume34
Issue number6
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Myosin Heavy Chains
Hematuria
Cataract
Mutation
Nonmuscle Myosin Type IIA
Phenotype
Inborn Genetic Diseases
Sensorineural Hearing Loss
Genetic Association Studies
Glomerulonephritis
Fathers
MYH9-Related Disorders
Genes

Keywords

  • Fechtner syndrome
  • MYH9-related disorders
  • nonmuscle myosin IIA
  • p.R1165C mutation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

MYH9-related disorders : Report on a patient of greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation. / Economou, Marina; Batzios, Spyros P.; Pecci, Alessandro; Printza, Nikoletta; Savoia, Anna; Barozzi, Serena; Theodoridou, Stamatia; Teli, Aikaterini; Psillas, Georgios; Zafeiriou, Dimitrios I.

In: Journal of Pediatric Hematology/Oncology, Vol. 34, No. 6, 08.2012, p. 412-415.

Research output: Contribution to journalArticle

Economou, Marina ; Batzios, Spyros P. ; Pecci, Alessandro ; Printza, Nikoletta ; Savoia, Anna ; Barozzi, Serena ; Theodoridou, Stamatia ; Teli, Aikaterini ; Psillas, Georgios ; Zafeiriou, Dimitrios I. / MYH9-related disorders : Report on a patient of greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation. In: Journal of Pediatric Hematology/Oncology. 2012 ; Vol. 34, No. 6. pp. 412-415.
@article{d281146652e24cc581eb7d7d89f350b6,
title = "MYH9-related disorders: Report on a patient of greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation",
abstract = "Myosin heavy chain-9 (MYH9)-related disorders represent a heterogenous group of hereditary diseases caused by mutations in the gene encoding the heavy chain of nonmuscle myosin IIA. May-Hegglin anomaly and Fechtner, Sebastian, and Epstein syndromes are the four phenotypes of the disease, characterized by congenital macrothrombocytopenia and distinguished by different combinations of clinical signs that may include glomerulonephritis, sensorineural hearing loss, and presenile cataract. The spectrum of mutations responsible for the disease is wide and the existence of genotype-phenotype correlation remains a critical issue. We report the first case of an MYH9-RD in a patient of Greek origin presenting with macroscopic hematuria and presenile cataract caused by a p.R1165C mutation. The same mutation was present in the patient's father, who exhibited no extrahematological features of the disease. The p.R1165C mutation is one of the MYH9 alterations whose prognostic significance is still poorly defined. Thus, the patients described add to the limited existing data on the MYH9 mutations and their resultant phenotypes.",
keywords = "Fechtner syndrome, MYH9-related disorders, nonmuscle myosin IIA, p.R1165C mutation",
author = "Marina Economou and Batzios, {Spyros P.} and Alessandro Pecci and Nikoletta Printza and Anna Savoia and Serena Barozzi and Stamatia Theodoridou and Aikaterini Teli and Georgios Psillas and Zafeiriou, {Dimitrios I.}",
year = "2012",
month = "8",
doi = "10.1097/MPH.0b013e318257a64b",
language = "English",
volume = "34",
pages = "412--415",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - MYH9-related disorders

T2 - Report on a patient of greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation

AU - Economou, Marina

AU - Batzios, Spyros P.

AU - Pecci, Alessandro

AU - Printza, Nikoletta

AU - Savoia, Anna

AU - Barozzi, Serena

AU - Theodoridou, Stamatia

AU - Teli, Aikaterini

AU - Psillas, Georgios

AU - Zafeiriou, Dimitrios I.

PY - 2012/8

Y1 - 2012/8

N2 - Myosin heavy chain-9 (MYH9)-related disorders represent a heterogenous group of hereditary diseases caused by mutations in the gene encoding the heavy chain of nonmuscle myosin IIA. May-Hegglin anomaly and Fechtner, Sebastian, and Epstein syndromes are the four phenotypes of the disease, characterized by congenital macrothrombocytopenia and distinguished by different combinations of clinical signs that may include glomerulonephritis, sensorineural hearing loss, and presenile cataract. The spectrum of mutations responsible for the disease is wide and the existence of genotype-phenotype correlation remains a critical issue. We report the first case of an MYH9-RD in a patient of Greek origin presenting with macroscopic hematuria and presenile cataract caused by a p.R1165C mutation. The same mutation was present in the patient's father, who exhibited no extrahematological features of the disease. The p.R1165C mutation is one of the MYH9 alterations whose prognostic significance is still poorly defined. Thus, the patients described add to the limited existing data on the MYH9 mutations and their resultant phenotypes.

AB - Myosin heavy chain-9 (MYH9)-related disorders represent a heterogenous group of hereditary diseases caused by mutations in the gene encoding the heavy chain of nonmuscle myosin IIA. May-Hegglin anomaly and Fechtner, Sebastian, and Epstein syndromes are the four phenotypes of the disease, characterized by congenital macrothrombocytopenia and distinguished by different combinations of clinical signs that may include glomerulonephritis, sensorineural hearing loss, and presenile cataract. The spectrum of mutations responsible for the disease is wide and the existence of genotype-phenotype correlation remains a critical issue. We report the first case of an MYH9-RD in a patient of Greek origin presenting with macroscopic hematuria and presenile cataract caused by a p.R1165C mutation. The same mutation was present in the patient's father, who exhibited no extrahematological features of the disease. The p.R1165C mutation is one of the MYH9 alterations whose prognostic significance is still poorly defined. Thus, the patients described add to the limited existing data on the MYH9 mutations and their resultant phenotypes.

KW - Fechtner syndrome

KW - MYH9-related disorders

KW - nonmuscle myosin IIA

KW - p.R1165C mutation

UR - http://www.scopus.com/inward/record.url?scp=84864328013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864328013&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e318257a64b

DO - 10.1097/MPH.0b013e318257a64b

M3 - Article

VL - 34

SP - 412

EP - 415

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 6

ER -